Cargando…
Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends
BACKGROUND: Drug induced liver injury (DILI) is an increasing cause of acute liver injury especially with increasing need for pharmacotherapy of widening comorbidities amongst our ever-aging population. Uncertainty however remains regarding both acceptable and widely agreeable diagnostic algorithms...
Autores principales: | Danjuma, Mohammed Ibn-Mas’ud, Sajid, Jamal, Fatima, Haajra, Elzouki, Abdel-Naser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922486/ https://www.ncbi.nlm.nih.gov/pubmed/31852121 http://dx.doi.org/10.1097/MD.0000000000018322 |
Ejemplares similares
-
Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020) -
Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020) -
Median arcuate ligament syndrome masquerading as mesenteric angina
por: Chapra, Ammar, et al.
Publicado: (2021) -
Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients: A protocol for systematic review and network meta-analysis using a generalized pairwise modeling methodology
por: Danjuma, Mohammed ibn-Mas’ud, et al.
Publicado: (2020) -
An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)